Search
Search Results
##search.searchResults.foundPlural##
-
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6188PDF: 2048HTML: 13969Untitled: 184figure: 159 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1316PDF: 733HTML: 931 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
901PDF: 550Html: 147 -
-
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1961PDF: 767HTML: 1026 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1353PDF: 478HTML: 3942 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2753PDF: 1192HTML: 2667Figure 1: 147 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1879PDF: 773HTML: 206 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
935PDF: 518HTML: 711 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2163PDF: 927HTML: 1869 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
906PDF: 467HTML: 65 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5053PDF: 1291HTML: 2726Cover letter: 174 -
-
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3646PDF: 1055HTML: 2261Figure 1: 194 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1338PDF: 797HTML: 3103 -
How I treat acute and persistent sickle cell pain
1843PDF: 1088HTML: 465 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3211PDF: 1310HTML: 2610 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2734PDF: 1086HTML: 11206 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3776PDF: 1421HTML: 8487 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3443PDF: 1136HTML: 4976Incidence age-standardized rates for HL across the Mediterranean basin: 176 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1109PDF: 584HTML: 6786 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2000PDF: 904HTML: 280 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4001PDF: 1534HTML: 841 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2520PDF: 1569HTML: 2338Table1: 176 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1430PDF: 895HTML: 208 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277550PDF: 1753HTML: 3837 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7248PDF: 2373HTML: 1705Table 1.: 183Table 2.: 199Table 3.: 180Table 4.: 180







